---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-123359"
form_type: "8-K"
ticker: "TKNO"
cik: "0001850902"
company_name: "Alpha Teknova, Inc."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:51:38.381990+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Teknova Q3 revenue up 17% to $9.6M; net loss $7.6M; guidance reiterates $35-38M

## Summary
- Total revenue $9.6M (+17% YoY); Clinical Solutions up 229% to $2.0M; Lab Essentials flat at $7.2M.
- GAAP net loss $7.6M ($0.15 EPS); adjusted EBITDA negative $5.0M; excludes $2.8M non-cash inventory charge.
- Gross margin 0.9% (29.8% excluding $2.8M charge) vs 18.0% in Q3 2023.
- Operating expenses down to $7.5M from $10.2M YoY, driven by reduced headcount and professional fees.
- 2024 free cash outflow outlook lowered to <$16M from <$18M; revenue guidance reaffirmed at $35-38M.

## SEC filing metadata
- accession: 0000950170-24-123359
- form_type: 8-K
- ticker: TKNO
- cik: 0001850902
- company_name: Alpha Teknova, Inc.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850902/000095017024123359/0000950170-24-123359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850902/000095017024123359/tkno-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-123359
- JSON: https://secwatch.observer/filing/0000950170-24-123359.json
- Plain text: https://secwatch.observer/filing/0000950170-24-123359.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.